Advertisement

October 2016 Briefing – Cardiology

0
Here are what the editors at HealthDay consider to be the most important developments in Cardiology for October 2016. This roundup includes the latest...
For patients at risk for sudden cardiac death

Similar Complication Rate for Transvenous, Subcutaneous ICDs

0
Nature of complications differs, with more nonlead-related complications for subcutaneous ICD
A long-term moderate-intensity physical activity intervention may reduce resting pulse rate among older adults

Benefit of Exercise on Resting Pulse Rate in Seniors Unclear

0
Statistically significant but clinically small average effect over the course of 2.6 years
Private sector employer-sponsored health insurance offerings were similar in 2013 and 2014

Few Changes in Employer-Sponsored Insurance 2013-2014

0
Only 3.5 percent of employers dropped coverage and 1.1 percent added coverage from 2013 to 2014
For patients with stable coronary artery disease

Depressive Symptoms Linked to Functional Status in CAD

0
Patients with class II, III, or IV functional status have increased risk of hospitalization for heart failure
For patients with left main coronary artery disease

PCI Noninferior to CABG for Left Main Coronary Artery Disease

0
PCI with everolimus-eluting stent noninferior for composite of death, stroke, or MI at three years
Low and high levels of high-density lipoprotein cholesterol are linked to increased mortality risk

Low and High HDL Tied to Increased Risk of Mortality

0
Study casts doubt on HDL as an independent cardiovascular disease risk factor
In an article published in Medical Economics

Useful Tips Offered for Addressing Negative Patient Reviews

0
Doctors should respond quickly, validate patient complaints, demonstrate willingness to take action
Cardiometabolic syndrome is associated with increased risk of subclinical atherosclerosis

Cardiometabolic Syndrome Ups Subclinical Atherosclerosis Risk

0
High fitness seemed to attenuate the risk in a cohort of men participating in a health screening program
The Amplatzer PFO Occluder device has been approved by the U.S. Food and Drug Administration to prevent another stroke among patients who have had at least one prior stroke involving a patent foramen ovale.

FDA Approves Device to Prevent Recurrent Strokes in PFO Patients

0
For patients who had prior stroke related to patent foramen ovale